During the past decade, Medizinische Universität Graz; Universitätsklinik für Neurologie conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medizinische Universität Graz; Universitätsklinik für Neurologie" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "CENTOGENE GmbH Rostock" with 2 trials sponsored, "Biogen" with 1 trials sponsored and "Newron Pharmaceuticals SPA" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medizinische Universität Graz; Universitätsklinik für Neurologie" #1 collaborator was "Shire Human Genetic Therapies, Inc." with 2 trials as a collaborator, "Elan Pharmaceuticals" with 1 trials as a collaborator and "Prothena Biosciences Limited" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Medizinische Universität Graz; Universitätsklinik für Neurologie" are "Cerebrovascular Accident" (2 trials), "Multiple Sclerosis, Relapsing-Remitting" (2 trials), "Fabry Disease" (1 trials), "Glioblastoma" (1 trials) and "Neuropathic Pain" (1 trials). Many other conditions were trialed in "Medizinische Universität Graz; Universitätsklinik für Neurologie" in a lesser frequency.

Most popular intervention types in "Medizinische Universität Graz; Universitätsklinik für Neurologie" are "Drug" (8 trials), "Other" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "No intervention" (2 trials), "1. Tesofensine (NS 2330)" (1 trials), "Bevacizumab" (1 trials) and "Lomustine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Medizinische Universität Graz; Universitätsklinik für Neurologie" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Medizinische Universität Graz; Universitätsklinik für Neurologie". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Medizinische Universität Graz; Universitätsklinik für Neurologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Medizinische Universität Graz; Universitätsklinik für Neurologie, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".